Abstract
In congestive heart failure patients, treatment with β-adrenoceptor antagonists improves symptoms and decreases mortality. However, intrinsic sympathomimetic activity of β-adrenoceptor antagonists might be disadvantageous in chronic heart failure. The nonselective β1- and β2-adrenoceptor antagonist bucindolol has failed to decrease mortality in clinical trials. A putative β4-adrenoceptor, which mediates positive inotropic effects by activation of the adenylate cyclase has been described. Recently, this putative β4-adrenoceptor has been identified to be a propranolol-insensitive state of the β1-adrenoceptor. The present study aimed to characterize whether bucindolol exhibits agonistic activity on this atypical β1-adrenoceptor state as one possible reason for clinical inefficiency. For comparison (S)-4-(3′-t-butylamino-1′-hydroxypropoxy)-benzimidozole-2 (CGP 12177), metoprolol, and nebivolol were investigated. Bucindolol did not reveal intrinsic sympathomimetic activity in electrically driven (1 Hz, 37°C), forskolin-stimulated, left ventricular papillary muscle strips (donor hearts, nonfailing; n = 5) and in right auricular trabeculae (bypass operation; n= 4). Functional studies on the propranolol-insensitive state of β1-adrenoceptors were performed in isolated muscle preparations after β1- and β2-adrenoceptor antagonism (propranolol, 1 μM), inhibition of β3-mediated inotropic effects ( n- nitro-l-arginine, 100 μM) and forskolin treatment (0.3 μM). Positive inotropic response to stimulation of atypical state β1-adrenoceptors could be demonstrated in right auricular as well as left ventricular human myocardium (CGP 12177 treatment, 10 μM). Under these conditions, also bucindolol, but not metoprolol and nebivolol, significantly increased contractility (all 10 μM). In conclusion, bucindolol but not metoprolol or nebivolol mediate positive inotropic effects in human myocardium due to activation of atypical state β1-adrenoceptors. Thus, the agonistic activity of bucindolol may influence outcome in heart failure patients.
Footnotes
-
This study was supported by the Deutsche Forschungsgemeinschaft (to R.H.G.S) and Köln Fortune (to K.B.). This paper contains part of the doctoral thesis of A.B.
- Abbreviations:
- NYHA
- New York Heart Association
- ISA
- intrinsic sympathomimetic activity
- CGP 12177
- (S)-4-(3′-t-butylamino-1′-hydroxypropoxy)-benzimidozole-2
- l-NMA
- N-nitro-l-arginine
- Received May 16, 2001.
- Accepted September 21, 2001.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|